HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sahar Assi Selected Research

tideglusib

2/2021The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells.
2/2021Tideglusib attenuates growth of neuroblastoma cancer stem/progenitor cells in vitro and in vivo by specifically targeting GSK-3β.
2/2021Correction to: The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sahar Assi Research Topics

Disease

6Neoplasms (Cancer)
02/2021 - 09/2018
3Glioblastoma (Glioblastoma Multiforme)
02/2021 - 09/2018
2Neuroblastoma
02/2021 - 09/2018
1Hypoalbuminemia
11/2021

Drug/Important Bio-Agent (IBA)

3tideglusibIBA
02/2021 - 02/2021
1Glycogen Synthase Kinase 3IBA
02/2021
1Pharmaceutical PreparationsIBA
02/2021
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
02/2021
1Sirolimus (Rapamycin)FDA Link
09/2018
1triciribineIBA
09/2018

Therapy/Procedure

4Therapeutics
02/2021 - 01/2019
1Surgical Amputation (Amputations)
11/2021
1Drug Therapy (Chemotherapy)
02/2021